Evidence map›Paper›PMID 30914516›Full record

ArticlemBio2019

Dynamic Dystroglycan Complexes Mediate Cell Entry of Lassa Virus.

Antonio Herrador, Chiara Fedeli, Emilia Radulovic, Kevin P Campbell, Hector Moreno, Gisa Gerold, Stefan Kunz

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Antonio HerradorInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Chiara FedeliInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Emilia RadulovicInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Kevin P CampbellHoward Hughes Medical Institute, Iowa City, Iowa, USA.
Hector MorenoInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Gisa GeroldTWINCORE - Center for Experimental and Clinical Infection Research, Institute for Experimental Virology, Hannover, Germany Gisa.Gerold@twincore.de Stefan.Kunz@chuv.ch.
Stefan KunzInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland Gisa.Gerold@twincore.de Stefan.Kunz@chuv.ch.ORCID 0000-0001-6030-9550
University of Lausanne · CHCenter for Experimental and Clinical Infection Research · DEUniversity of Iowa · US

Funding

Therapeutic Potential of ESC-Derived Myogenic PrecursorsU54NS053672 · NINDS · UNIVERSITY OF IOWA · PI CAMPBELL, KEVIN P. · 2005 to 2019
$22.0M
Howard Hughes Medical InstituteNINDS NIH HHS U54 NS053672
6 · The paper itself

Abstract

Recognition of functional receptors by viruses is a key determinant for their host range, tissue tropism, and disease potential. The highly pathogenic Lassa virus (LASV) currently represents one of the most important emerging pathogens. The major cellular receptor for LASV in human cells is the ubiquitously expressed and evolutionary highly conserved extracellular matrix receptor dystroglycan (DG). In the host, DG interacts with many cellular proteins in a tissue-specific manner. The resulting distinct supramolecular complexes likely represent the functional units for viral entry, and preexisting protein-protein interactions may critically influence DG's function in productive viral entry. Using an unbiased shotgun proteomic approach, we define the largely unknown molecular composition of DG complexes present in highly susceptible epithelial cells that represent important targets for LASV during viral transmission. We further show that the specific composition of cellular DG complexes can affect DG's function in receptor-mediated endocytosis of the virus. Under steady-state conditions, epithelial DG complexes underwent rapid turnover via an endocytic pathway that shared some characteristics with DG-mediated LASV entry. However, compared to steady-state uptake of DG, LASV entry via DG occurred faster and critically depended on additional signaling by receptor tyrosine kinases and the downstream effector p21-activating kinase. In sum, we show that the specific molecular composition of DG complexes in susceptible cells is a determinant for productive virus entry and that the pathogen can manipulate the existing DG-linked endocytic pathway. This highlights another level of complexity of virus-receptor interaction and provides possible cellular targets for therapeutic antiviral intervention.

Indexed as

Virus InternalizationCell LineDystroglycansEpithelial CellsHumansLassa virusMultiprotein ComplexesReceptors, VirusDystroglycansMultiprotein ComplexesReceptors, Virusarenavirusproteomicstropismviral entryvirus receptor

Identifiers

PMID30914516
PMCPMC6437060
OpenAlexW2923181860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.